Skip to content

The mechanism of prefrontal cortex function affecting daytime hypersomnia

The mechanism of prefrontal cortex function affecting daytime hypersomnia - The mechanism of prefrontal cortex function affecting daytime hypersomnia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071557
Enrollment
Unknown
Registered
2023-05-18
Start date
2023-05-20
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Excessive daytime sleepiness

Interventions

Experimental group:true tDCS
Observation group:collecting cortical function data

Sponsors

Tangdu Hospital, Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria of OSA in adults in ICSD-3, and meet both A and B or C. A. At least one of the following occurs: ?. Sleepy, non-restorative sleep, fatigue, insomnia; ?. Hold awake, gasp, suffocate; ?. Snoring and/or interrupted breathing observed by bed partners or others during sleep; ?. Diagnosis of hypertension, mood disorders, cognitive dysfunction, coronary heart disease, stroke, congestive heart failure, atrial fibrillation, type 2 diabetes; B. Obstructive respiratory events (obstructive or combined apnea, hypopnea, respiratory effort-related arousal) =5 times per hour through PSG monitoring or home monitoring; C. PSG or sleep-breathing home monitoring confirmation: obstructive respiratory events (apnea, hypopnea, respiratory effort-related arousal) =15 / hour by PSG or home monitoring. 2), ESS=10 points; 3), right hand; 4) Age range 18-65. 5) Years of education =12 years, education level of junior high school or above; 6) Never received PAP or surgery for OSA disease; 7) Sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Other severe neuropsychiatric diseases or brain structural abnormalities in the past; 2) History of serious systemic diseases such as heart, lung, liver, kidney and thyroid, history of infectious diseases such as syphilis and AIDS, history of severe brain trauma and surgery, history of heavy alcoholism, long-term use of benzodiazepines and drug addiction; 3) Metal foreign bodies in the body, including stents, DBS treatment devices, cardiac pacemakers, cochlear implants, etc.; 4) Can not cooperate with the inspection operation; 5) Local skin diseases on the scalp; 5) The physician assessed other conditions that were not suitable for study participation.

Design outcomes

Primary

MeasureTime frame
Stanford Sleepiness Scale (SSS);

Secondary

MeasureTime frame
Epworth Sleepiness Scale(ESS);Karolinska Sleepiness Scale(KSS);Insomnia Severity Indeex(ISI));Pittsburgh?sleep quality index(PSQI);Hamilton Depression Scale(HAMD);Hamilton Anxiety Scale(HAMA);Mini-Mental State Examination(MMSE);Montreal Cognitive Assessment(MoCA);Morningness-Eveningness Questionnaire(MEQ);Right-handed questionnaire;actiwatch;polysomnography;PVT-ERP;corsi-ERP;rest motor threshold(rMT);active motor threshold(aMT);cortical silence period(CSP);input-output curve(I-O curve);intracortical inhibition(ICI);intracortical facilitation(ICF));Motion-evoked potentials(MEP);electroencephalogram(EEG);

Countries

China

Contacts

Public Contactcheng jinxiang

Tangdu Hospital, Fourth Military Medical University

Chengjinxiang423@foxmail.com+86 137 2075 0898

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026